Chengdu Easton Biopharmaceuticals Co., Ltd. (SHA:688513)

SHA:688513 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 21, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	10,078	5,252	7,659	7,306	5,572	5,715
Market Cap Growth	89.12%	-31.43%	4.83%	31.12%	-2.50%	-
Enterprise Value	8,645	4,010	6,419	6,121	3,987	4,172
Last Close Price	57.80	29.84	42.48	40.11	30.07	30.63
PE Ratio	42.15	22.05	33.81	29.64	23.97	32.08
Forward PE	38.28	16.21	25.33	22.56	-	-
PS Ratio	7.58	3.89	6.86	6.24	5.45	6.20
PB Ratio	3.52	1.95	2.94	2.99	2.43	2.73
P/TBV Ratio	3.56	1.97	2.98	3.03	2.47	2.77
P/FCF Ratio	39.95	36.02	76.60	-	-	-
P/OCF Ratio	30.05	19.95	27.83	48.09	37.75	36.51
EV/Sales Ratio	6.50	2.97	5.75	5.23	3.90	4.53
EV/EBITDA Ratio	36.69	16.05	28.47	28.37	23.72	27.50
EV/EBIT Ratio	58.35	23.81	42.17	38.89	29.43	35.14
EV/FCF Ratio	34.27	27.50	64.19	-	-	-
Debt / Equity Ratio	0.05	0.04	0.09	0.04	0.01	0.02
Debt / EBITDA Ratio	0.57	0.46	0.99	0.49	0.12	0.26
Debt / FCF Ratio	0.53	0.78	2.24	-	-	-
Asset Turnover	0.38	0.40	0.35	0.40	0.39	0.52
Inventory Turnover	1.76	1.97	1.50	1.63	1.56	1.49
Quick Ratio	3.08	2.87	2.57	2.89	3.77	4.61
Current Ratio	3.50	3.23	2.85	3.23	4.11	4.92
Return on Equity (ROE)	8.71%	8.99%	8.98%	10.41%	10.60%	12.76%
Return on Assets (ROA)	2.65%	3.12%	2.99%	3.40%	3.19%	4.22%
Return on Invested Capital (ROIC)	9.70%	11.80%	11.39%	14.74%	19.36%	26.30%
Return on Capital Employed (ROCE)	5.00%	6.00%	5.70%	6.30%	5.80%	5.50%
Earnings Yield	2.40%	4.54%	2.96%	3.37%	4.17%	3.12%
FCF Yield	2.50%	2.78%	1.31%	-2.56%	-2.20%	-0.74%
Dividend Yield	0.74%	1.44%	0.93%	0.95%	1.76%	0.67%
Payout Ratio	32.12%	31.11%	31.37%	38.96%	15.66%	0.39%
Buyback Yield / Dilution	0.11%	1.04%	-0.14%	-0.37%	-19.70%	-11.50%
Total Shareholder Return	0.84%	2.48%	0.79%	0.58%	-17.94%	-10.84%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.